Mette M. Lauridsen, James B. Wade, Jasmohan S. Bajaj – 28 October 2015 – Watch a video presentation of this article
Lin Fan, Kwame Owusu‐Edusei, Sarah F. Schillie, Trudy V. Murphy – 28 October 2015 – In an era of antiviral treatment, reexamination of the cost‐effectiveness of strategies to prevent perinatal hepatitis B virus (HBV) transmission in the United States is needed. We used a decision tree and Markov model to estimate the cost‐effectiveness of the current U.S. strategy and two alternatives: (1) Universal hepatitis B vaccination (HepB) strategy: No pregnant women are screened for hepatitis B surface antigen (HBsAg).
Lola M. Reid, Praveen Sethupathy – 27 October 2015
Stephan Urban – 26 October 2015
Francesco Tandoi, Mauro Salizzoni, Andrea Brunati, Francesco Lupo, Renato Romagnoli – 22 October 2015
Giovanni Targher, Christopher D. Byrne – 21 October 2015
Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Henry Lik‐Yuen Chan – 21 October 2015
Jean‐François Dufour – 20 October 2015
Jean‐François Dufour – 20 October 2015
Chun‐Ming Wong, Lai Wei, Cheuk‐Ting Law, Daniel Wai‐Hung Ho, Felice Ho‐Ching Tsang, Sandy Leung‐Kuen Au, Karen Man‐Fong Sze, Joyce Man‐Fong Lee, Carmen Chak‐Lui Wong, Irene Oi‐Lin Ng – 20 October 2015 – Epigenetic deregulation plays an important role in liver carcinogenesis. Using transcriptome sequencing, we examined the expression of 591 epigenetic regulators in hepatitis B‐associated human hepatocellular carcinoma (HCC). We found that aberrant expression of epigenetic regulators was a common event in HCC.